Hi-Tech Pharmacal Co, Inc. (HITK) Tops Q1 EPS Views

September 7, 2011 8:01 AM EDT
Hi-Tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q1 EPS of $1.05, $0.21 better than the analyst estimate of $0.84. Revenue for the quarter came in at $56.21 million versus the consensus estimate of $54.07 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings